Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.
Hospital-Acquired Infection Control Market Forecast Highlighting Growth From $37.69 Billion To $46.31 Billion
The market dedicated to controlling infections acquired within healthcare settings has witnessed robust expansion recently. Projections indicate a rise in its valuation from $35.75 billion in 2025 to $37.7 billion in 2026, reflecting a compound annual growth rate of 5.4%. Several factors contributed to this growth during the preceding period, including an escalating number of hospital-associated infections, a greater reliance on invasive medical interventions, heightened consciousness regarding patient safety protocols, the proliferation of intensive care units, and the implementation of more stringent hospital hygiene mandates.
Within the domain of hospital-acquired infection control, a robust expansion is anticipated over the forthcoming years, projecting a market valuation of $46.32 billion by the year 2030. This upward trajectory is fueled by a compound annual growth rate (CAGR) of 5.3%, driven by several key factors including heightened regulatory mandates concerning infection prevention, a greater embrace of automated sterilization methods, escalating requirements for swift microbial identification, the broadening scope of monitoring and reporting frameworks, and amplified investments in the foundational elements of hospital infection mitigation. Prominently shaping this period are the intensified efforts to thwart cross-contamination within healthcare settings, a surge in the implementation of sophisticated sterilization and decontamination procedures, a significant emphasis on ongoing infection surveillance, the proliferation of automated and advanced disinfection technologies, and a growing need for all-encompassing infection control strategies.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7694&type=smp
Hospital-Acquired Infection Control Market Growth Factors: Which Forces Are Supporting Market Expansion?
Anticipated escalation in healthcare spending is expected to be a primary catalyst for the expansion of the market focused on controlling hospital-acquired infections. This spending encompasses all outlays for healthcare services, goods, and initiatives, calculated across various scales from individual to global. With rising healthcare budgets, medical institutions are increasingly equipped to invest more in sophisticated infection prevention technologies, which include cutting-edge disinfection methods, intelligent surveillance equipment, and other advancements designed to bolster infection control efficacy. Illustrating this trend, data from the UK’s Office for National Statistics in May 2024 revealed that total healthcare expenditure saw a nominal rise of 5.6% from 2022 to 2023, a significant acceleration from the 0.9% growth observed in 2022. Consequently, the upward trajectory of healthcare expenditure is set to fuel the ongoing development of the hospital-acquired infection control market.
Hospital-Acquired Infection Control Market Segmentation: How Is The Market Structured Across Key Categories?
The hospital-acquired infection control market covered in this report is segmented –
1) By Product: Sterilizers, Disinfectors, Endoscope Reprocessors, Microbial Testing Instruments, Consumables, Disinfectants, Infection Prevention And Surveillance Software, Other Products
2) By Technology: Phenotypic Methods, Genotypic Methods
3) By Diseases: Hospital Acquired Pneumonia, Bloodstream Infections, Surgical Site Infections, Gastrointestinal Infections, Urinary Tract Infection, Other Diseases
4) By Application: Disease Testing, Drug-Resistance Testing
5) By End User: Hospitals, ICUs, Ambulatory Surgical, Diagnostic Centers, Nursing Homes, Maternity Centers, Other End Users
Subsegments:
1) By Sterilizers: Steam Sterilizers, Ethylene Oxide Sterilizers, Hydrogen Peroxide Sterilizers
2) By Disinfectors: Washer Disinfectors, Automated Disinfectors
3) By Endoscope Reprocessors: High-Level Disinfection Reprocessors, Automated Endoscope Reprocessors
4) By Microbial Testing Instruments: Culture Systems, Rapid Microbial Testing Systems
5) By Consumables: Sterilization Wraps, Filters, Personal Protective Equipment (PPE)
6) By Disinfectants: Alcohol-based Disinfectants, Chlorine-based Disinfectants, Quaternary Ammonium Compounds
7) By Infection Prevention And Surveillance Software: Surveillance Software Solutions, Data Management Software
8) By Other Products: Cleaning Equipment, Air Purification Systems
Hospital-Acquired Infection Control Market Industry Trends: What Changes Are Reshaping Demand?
Leading entities within the hospital-acquired infection control sector are prioritizing the creation of novel technological advancements, exemplified by AI systems aimed at facilitating the early detection of sepsis, thereby improving patient results through expedited diagnosis and intervention. An AI system for sepsis identification involves sophisticated technological frameworks employing artificial intelligence and machine learning methodologies to discern nascent indicators of sepsis in individuals. Illustratively, in April of 2024, Prenosis Inc., a medical practice situated in the United States, secured FDA clearance for its Sepsis ImmunoScore, marking the inaugural AI-powered platform engineered for the prediction of sepsis, a perilous ailment capable of precipitating grave health consequences. This groundbreaking instrument elevates the efficacy of preemptive identification by analyzing data streams in real-time, empowering healthcare providers to enact swifter and more impactful interventions. The incorporation of AI functions to augment the decision-making capabilities of clinical personnel, rather than supplanting their roles, with the ultimate objectives of enhancing patient well-being and curtailing medical expenditures.
Hospital-Acquired Infection Control Market Competitive Landscape And Leading Companies
Major companies operating in the hospital-acquired infection control market are Johnson and Johnson, P&G Professional, Honeywell International Inc., MMM Group, 3M Company, Becton Dickinson and Company, Reckitt Benckiser Group plc., Ecolab Inc, Olympus Corporation, Miele Group, Biomerieux SA, Getinge AB, Halyard Health Inc., Ansell Limited, Sotera Health LLC, Contec Inc., Cantel Medical Corp., Belimed AG, Nanosonics Limited, Advanced Sterilization Products Services Inc, Steelco S.P.A, Schülke & Mayr GmbH, Metrex Research LLC, Tristel Solutions Ltd., Whiteley Corporation, PDI Inc., Steris Healthcare PVT Ltd, Matachana Group, Pal International Ltd., Xttrium Laboratories Inc., Zep Inc.
Access The Complete Hospital-Acquired Infection Control Market Report:
Hospital-Acquired Infection Control Market Geographic Analysis: Where Is Demand Growing The Fastest?
North Americawas the largest region in the hospital-acquired infection control market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the hospital-acquired infection control market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
